Mr. Speaker, I will rely on the advice of the Canadian Generic Pharmaceutical Association, the Canadian Federation of Nurses Unions, the Canadian Health Coalition, and in fact, Health Canada itself. They all say that the direction of prescription drug costs is way up. Nobody is estimating it down. We are already in a huge crunch.
Canadians pay more for drugs than any other consumers, and we are the only country in the world that has a public health care system that does not have a pharmacare plan. We have work to do. It is a service we could provide, which New Democrats are committed to providing. We certainly are concerned that entering into a forever trade deal like this would limit those opportunities.
This is absolutely a place to slow down, as the Liberals proposed in the previous Parliament, and study this and be much more clear. With 215 out of 338 members of this House newly elected, we would certainly all benefit from more study in this area.